MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center-Reference-Cited by-同舟云学术

MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center

Published:2021-07-20 Issue:11 Volume:46 Page:5142-5151
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Hernandez-Meza Gabriela,Vietti Violi Naik,Said Daniela,Novogrodsky Eitan,Villavisanis Dillan,Maron Samuel Z.,Frere Justin,Schiano Thomas D.,Friedman Scott,Boffetta Paolo,Branch Andrea,Taouli Bachir^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-021-03212-7.pdf

Reference45 articles.

1. Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA (2016) Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 122 (9):1312-1337. doi:https://doi.org/10.1002/cncr.29936

2. Xu J (2018) Trends in Liver Cancer Mortality Among Adults Aged 25 and Over in the United States, 2000-2016. NCHS Data Brief (314):1-8

3. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival. J Natl Cancer Inst 109 (9). doi:https://doi.org/10.1093/jnci/djx030

4. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (7):417-422. doi:https://doi.org/10.1007/s00432-004-0552-0

5. McGlynn KA, Petrick JL, London WT (2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19 (2):223-238. doi:https://doi.org/10.1016/j.cld.2015.01.001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage Black patients;Cancer Medicine;2024-01-17

2. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening;European Radiology;2023-07-18

3. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score;Abdominal Radiology;2022-10-15

4. Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach;Drug Delivery;2022-09-08

5. Spontaneous Regression of Hepatocellular Carcinoma From Autoinfarction and Implications on Liver Transplantation;ACG Case Reports Journal;2022-07